BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 1841694)

  • 1. In pre-sterol carrier protein 2 (SCP2) in solution the leader peptide 1-20 is flexibly disordered, and residues 21-143 adopt the same globular fold as in mature SCP2.
    Weber FE; Dyer JH; López García F; Werder M; Szyperski T; Wüthrich K; Hauser H
    Cell Mol Life Sci; 1998 Jul; 54(7):751-9. PubMed ID: 9711242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Backbone 1H, 13C, and 15N chemical shift assignments for human SERF2.
    Sahoo BR; Subramanian V; Bardwell JCA
    Biomol NMR Assign; 2024 Jun; 18(1):51-57. PubMed ID: 38466543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative, high-throughput screen for protein stability.
    Ghaemmaghami S; Fitzgerald MC; Oas TG
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8296-301. PubMed ID: 10890887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR chemical shift perturbation mapping of DNA binding by a zinc-finger domain from the yeast transcription factor ADR1.
    Schmiedeskamp M; Rajagopal P; Klevit RE
    Protein Sci; 1997 Sep; 6(9):1835-48. PubMed ID: 9300483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assignments of 1H-15N magnetic resonances and identification of secondary structure elements of the lambda-cro repressor.
    Matsuo H; Shirakawa M; Ohkubo T; Yamazaki T; Kyogoku Y
    J Biomol NMR; 1991 Jul; 1(2):191-204. PubMed ID: 1841694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lambda cro repressor complex with OR3 DNA: 15N NMR observations.
    Leighton P; Lu P
    Biochemistry; 1987 Nov; 26(23):7262-71. PubMed ID: 2962634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H NMR studies of lambda cro repressor. 2. Sequential resonance assignments of the 1H NMR spectrum.
    Weber PL; Wemmer DE; Reid BR
    Biochemistry; 1985 Aug; 24(17):4553-62. PubMed ID: 2933070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assignments of backbone 1H, 13C, and 15N resonances and secondary structure of ribonuclease H from Escherichia coli by heteronuclear three-dimensional NMR spectroscopy.
    Yamazaki T; Yoshida M; Kanaya S; Nakamura H; Nagayama K
    Biochemistry; 1991 Jun; 30(24):6036-47. PubMed ID: 1646006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydrofolate reductase: sequential resonance assignments using 2D and 3D NMR and secondary structure determination in solution.
    Carr MD; Birdsall B; Frenkiel TA; Bauer CJ; Jimenez-Barbero J; Polshakov VI; McCormick JE; Roberts GC; Feeney J
    Biochemistry; 1991 Jun; 30(25):6330-41. PubMed ID: 1905571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assignment of the side-chain 1H and 13C resonances of interleukin-1 beta using double- and triple-resonance heteronuclear three-dimensional NMR spectroscopy.
    Clore GM; Bax A; Driscoll PC; Wingfield PT; Gronenborn AM
    Biochemistry; 1990 Sep; 29(35):8172-84. PubMed ID: 2261471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assignment of the three methionyl carbonyl carbon resonances in Streptomyces subtilisin inhibitor by a carbon-13 and nitrogen-15 double-labeling technique. A new strategy for structural studies of proteins in solution.
    Kainosho M; Tsuji T
    Biochemistry; 1982 Nov; 21(24):6273-9. PubMed ID: 7150557
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure of the lambda tof repressor protein in solution. Heat stability and its relation to binding ability to DNA.
    Iwahashi H; Akutsu H; Kobayashi Y; Kyogoku Y; Ono T; Koga H; Horiuchi T
    J Biochem; 1982 Apr; 91(4):1213-21. PubMed ID: 7047511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the cro repressor from bacteriophage lambda and its interaction with DNA.
    Anderson WF; Ohlendorf DH; Takeda Y; Matthews BW
    Nature; 1981 Apr; 290(5809):754-8. PubMed ID: 6452580
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.